Stay updated on Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Sign up to get notified when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.4 to v2.15.0, indicating a revision in the content. The phrase 'Here’s how you know' has been removed and replaced with a similar phrase.
    Difference
    1.0%
    Check dated 2025-04-16T01:43:00.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-08T20:19:07.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    51 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-03-03T22:21:48.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T09:49:13.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T07:58:38.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T22:26:14.000Z thumbnail image

Stay in the know with updates to Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.